# Coccidioidomycosis Collaborative Research Centers (P01 Clinical Trial Not Allowed)

Source: https://welltoldgrants.com/grants/rfa-ai-27-012-coccidioidomycosis-collaborative-research-centers-p01/  
Official notice: https://www.grants.gov/search-results-detail/360878

> National Institutes of Health offered grants of up to $1.2 million to nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses. It expected to make about 4 awards worth $4.8 million in total. Applications closed on July 9, 2026.

| Field | Value |
|---|---|
| Opportunity number | RFA-AI-27-012 |
| Agency | National Institutes of Health |
| Status | Forecast |
| Deadline | July 9, 2026 |
| Award ceiling | $1.2 million |
| Award floor | not stated |
| Expected awards | 4 |
| Total funding | $4.8 million |
| Cost sharing | not required |
| Assistance Listings | 93.855 |

## Who can apply

- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Native American tribal governments (Federally recognized)
- Public housing authorities/Indian housing authorities
- Native American tribal organizations (other than Federally recognized tribal governments)
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- Private institutions of higher education
- For profit organizations other than small businesses
- Small businesses
- Others (see text field entitled "Additional Information on Eligibility" for clarification)

Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility. Foreign Organizations/International CollaborationsNon-domestic (non-U.S.) Entities (Foreign Organization) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

## What the grant funds

The purpose of the notice of funding opportunity (NOFO) is to solicit applications for a Coccidioidomycosis Collaborative Research Centers (CCRC) program. This new initiative will establish highly collaborative, multi-disciplinary, research teams to conduct translational and clinical research to support the development of a Valley fever vaccine as outlined in NIAID's Strategic Plan for Research to Develop a Valley fever Vaccine.

## Questions people ask

### Is RFA-AI-27-012 still open?

No. It closed on July 9, 2026.

### Who can apply for Coccidioidomycosis Collaborative Research Centers (P01 Clinical Trial Not Allowed)?

National Institutes of Health accepted applications from nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses. The notice adds further conditions, so read its eligibility section.

### What is the deadline for Coccidioidomycosis Collaborative Research Centers (P01 Clinical Trial Not Allowed)?

Closed July 9, 2026. Applications are no longer accepted; the program's newer notices are on this page when there are any.

### How much funding is available?

Awards of up to $1.2 million each. About $4.8 million in total across about 4 awards.

### Who has won Allergy and Infectious Diseases Research grants before?

The largest recipients over five fiscal years were Fred Hutchinson Cancer Center, Duke University, University of California, Los Angeles. The program made 13,282 awards worth $22 billion in that time.